Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A next-generation GMMA-based vaccine candidate to fight shigellosis.
Rossi O, Citiulo F, Giannelli C, Cappelletti E, Gasperini G, Mancini F, Acquaviva A, Raso MM, Sollai L, Alfini R, Aruta MG, Vitali CG, Pizza M, Necchi F, Rappuoli R, Martin LB, Berlanda Scorza F, Colucci AM, Micoli F. Rossi O, et al. Among authors: acquaviva a. NPJ Vaccines. 2023 Sep 5;8(1):130. doi: 10.1038/s41541-023-00725-8. NPJ Vaccines. 2023. PMID: 37670042 Free PMC article.
Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults.
Frenck RW Jr, Conti V, Ferruzzi P, Ndiaye AGW, Parker S, McNeal MM, Dickey M, Granada JP, Cilio GL, De Ryck I, Necchi F, Suvarnapunya AE, Rossi O, Acquaviva A, Chandrasekaran L, Clarkson KA, Auerbach J, Marchetti E, Kaminski RW, Micoli F, Rappuoli R, Saul A, Martin LB, Podda A. Frenck RW Jr, et al. Among authors: acquaviva a. EClinicalMedicine. 2021 Aug 13;39:101076. doi: 10.1016/j.eclinm.2021.101076. eCollection 2021 Sep. EClinicalMedicine. 2021. PMID: 34430837 Free PMC article.
Complement-mediated serum bactericidal activity of antibodies elicited by the Shigella sonnei GMMA vaccine in adults from a shigellosis-endemic country: Exploratory analysis of a Phase 2a randomized study.
Kapulu MC, Nakakana U, Sciré AS, Sarakinou E, Conti V, Rossi O, Acquaviva A, Necchi F, Obiero CW, Martin LB, Bejon P, Njuguna P, Micoli F, Podda A. Kapulu MC, et al. Among authors: acquaviva a. Front Immunol. 2022 Sep 9;13:971866. doi: 10.3389/fimmu.2022.971866. eCollection 2022. Front Immunol. 2022. PMID: 36203568 Free PMC article. Clinical Trial.
Age-dependent acquisition of IgG antibodies to Shigella serotypes-a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination.
Kapulu MC, Muthumbi E, Otieno E, Rossi O, Ferruzzi P, Necchi F, Acquaviva A, Martin LB, Orindi B, Mwai K, Kibet H, Mwanzu A, Bigogo GM, Verani JR, Mbae C, Nyundo C, Agoti CN, Nakakana UN, Conti V, Bejon P, Kariuki S, Scott JAG, Micoli F, Podda A. Kapulu MC, et al. Among authors: acquaviva a. Front Immunol. 2024 Feb 1;15:1340425. doi: 10.3389/fimmu.2024.1340425. eCollection 2024. Front Immunol. 2024. PMID: 38361949 Free PMC article.
Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccine.
Conti V, Rossi O, Clarkson KA, Mancini F, Nakakana UN, Sarakinou E, Callegaro A, Ferruzzi P, Acquaviva A, Arora AK, Marchetti E, Necchi F, Frenck RW Jr, Martin LB, Kaminski RW, Podda A, Micoli F. Conti V, et al. Among authors: acquaviva a. NPJ Vaccines. 2024 Mar 8;9(1):56. doi: 10.1038/s41541-024-00822-2. NPJ Vaccines. 2024. PMID: 38459072 Free PMC article.
Protective effect of Group B Streptococcus type-III polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models.
Chiarot E, Spagnuolo A, Maccari S, Naimo E, Acquaviva A, Cecchi R, Galletti B, Fabbrini M, Mori E, Ruggiero P, Grandi G, Fontana MR, Bensi G, Margarit I. Chiarot E, et al. Among authors: acquaviva a. Sci Rep. 2018 Feb 7;8(1):2593. doi: 10.1038/s41598-018-20609-5. Sci Rep. 2018. PMID: 29416049 Free PMC article.
168 results